Suppr超能文献

宫颈癌高剂量率腔内近距离放疗期间的最佳膀胱充盈:一项剂量学研究。

Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study.

作者信息

Mahantshetty Umesh, Shetty Saurabha, Majumder Dipanjan, Adurkar Pranjal, Swamidas Jamema, Engineer Reena, Chopra Supriya, Shrivastava Shyamkishore

机构信息

Department of Radiation Oncology, Tata Memorial Hospital.

Department of Medical Physics, Tata Memorial Hospital, Parel, Mumbai, India.

出版信息

J Contemp Brachytherapy. 2017 Apr;9(2):112-117. doi: 10.5114/jcb.2017.67502. Epub 2017 Apr 30.

Abstract

PURPOSE

The aim of this study is to compare 3D dose volume histogram (DVH) parameters of bladder and other organs at risk with different bladder filling protocol during high-dose-rate intracavitary brachytherapy (HDR-ICBT) in cervical cancer, and to find optimized bladder volume.

MATERIAL AND METHODS

This dosimetric study was completed with 21 patients who underwent HDR-ICBT with computed tomography/magnetic resonance compatible applicator as a routine treatment. Computed tomography planning was done for each patient with bladder emptied (series 1), after 50 ml (series 2), and 100 ml (series 3) bladder filling with a saline infusion through the bladder catheter. Contouring was done on the Eclipse Planning System. 7 Gy to point A was prescribed with the standard loading patterns. Various 3D DVH parameters including 0.1 cc, 1 cc, 2 cc doses and mean doses to the OAR's were noted. Paired -test was performed.

RESULTS

The mean (± SD) bladder volume was 64.5 (± 25) cc, 116.2 (± 28) cc, and 172.9 (± 29) cc, for series 1, 2, and 3, respectively. The 0.1 cm,1 cm, 2 cm mean bladder doses for series 1, series 2, and series 3 were 9.28 ± 2.27 Gy, 7.38 ± 1.72 Gy, 6.58 ± 1.58 Gy; 9.39 ± 2.28 Gy, 7.85 ± 1.85 Gy, 7.05 ± 1.59 Gy, and 10.09 ± 2.46 Gy, 8.33 ± 1.75 Gy, 7.6 ± 1.55 Gy, respectively. However, there was a trend towards higher bladder doses in series 3. Similarly, for small bowel dose 0.1 cm, 1 cm, and 2 cm in series 1, 2, and 3 were 5.44 ± 2.2 Gy, 4.41 ± 1.84 Gy, 4 ± 1.69 Gy; 4.57 ± 2.89 Gy, 3.78 ± 2.21 Gy, 3.35 ± 2.02 Gy, and 4.09 ± 2.38 Gy, 3.26 ± 1.8 Gy, 3.05 ± 1.58 Gy. Significant increase in small bowel dose in empty bladder (series 1) compared to full bladder (series 3) ( = 0.03) was noted. However, the rectal and sigmoid doses were not significantly affected with either series.

CONCLUSIONS

Bladder filling protocol with 50 ml and 100 ml was well tolerated and achieved a reasonably reproducible bladder volume during cervical brachytherapy. In our analysis so far, there is no significant impact of bladder filling on DVH parameters, although larger bladders tend to have higher doses. Small bowel doses are lesser with higher bladder volumes. Further evaluation and validation are necessary.

摘要

目的

本研究旨在比较宫颈癌高剂量率腔内近距离放射治疗(HDR-ICBT)期间不同膀胱充盈方案下膀胱及其他危及器官的三维剂量体积直方图(DVH)参数,以寻找优化的膀胱体积。

材料与方法

本剂量学研究纳入21例行HDR-ICBT且使用计算机断层扫描/磁共振兼容施源器作为常规治疗的患者。对每位患者进行计算机断层扫描计划,分别在膀胱排空(系列1)、注入50 ml(系列2)和100 ml(系列3)生理盐水后通过膀胱导管充盈膀胱时进行。在Eclipse计划系统上进行轮廓勾画。按照标准加载模式向A点处方7 Gy剂量。记录包括0.1 cc、1 cc、2 cc剂量以及危及器官平均剂量在内的各种三维DVH参数。进行配对t检验。

结果

系列1、2、3的平均(±标准差)膀胱体积分别为64.5(±25)cc、116.2(±28)cc和172.9(±29)cc。系列1、2、3的0.1 cm、1 cm、2 cm膀胱平均剂量分别为9.28±2.27 Gy、7.38±1.72 Gy、6.58±1.58 Gy;9.39±2.28 Gy、7.85±1.85 Gy、7.05±1.59 Gy;以及10.09±2.46 Gy、8.33±1.75 Gy、7.6±1.55 Gy。然而,系列3中膀胱剂量有升高趋势。同样,系列1、2、3中小肠0.1 cm、1 cm和2 cm剂量分别为5.44±2.2 Gy、4.41±1.84 Gy、4±1.69 Gy;4.57±2.89 Gy、3.78±2.21 Gy、3.35±2.02 Gy;以及4.09±2.38 Gy、3.26±1.8 Gy、3.05±1.58 Gy。与膀胱充盈(系列3)相比,膀胱空虚(系列1)时小肠剂量显著增加(P = 0.03)。然而,直肠和乙状结肠剂量在各系列中均未受到显著影响。

结论

50 ml和100 ml的膀胱充盈方案耐受性良好,在宫颈癌近距离放射治疗期间能获得合理可重复的膀胱体积。在我们目前的分析中,尽管较大的膀胱往往剂量较高,但膀胱充盈对DVH参数无显著影响。膀胱体积越大,小肠剂量越小。需要进一步评估和验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5210/5437088/0029928f57d7/JCB-9-29875-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验